The FDA has made public dozens of warning letters sent to drug companies accused of misleading or deceptive advertising.
The disclosures come after the agency said Sept. 9 it would be sending thousands of warning letters and 100 cease-and-desist letters to drug companies over deceptive advertising.
A day later, President Donald Trump signed an executive order directing HHS and the FDA to require drug companies to include full safety warnings in advertisements. The warning letters outline alleged violations and can lead to regulatory action if companies choose to not comply.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
